Increasing focus on targeted therapies is driving the growth of the global adalimumab drugs market. Biologic adoption, therapeutic innovations, and rising patient demand are key factors. The market is anticipated to grow at a CAGR of 5.10% from 2025 to 2034, creating significant prospects for pharmaceutical companies, healthcare providers, and key industry stakeholders worldwide. https://www.expertmarketresearch.com/reports/adalimumab-drugs-market